Global Retirement Partners LLC Buys New Shares in Astera Labs, Inc. $ALAB

Global Retirement Partners LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, HoldingsChannel reports. The institutional investor purchased 2,847 shares of the company’s stock, valued at approximately $1,375,000.

Several other large investors have also recently bought and sold shares of ALAB. Royal Bank of Canada increased its stake in shares of Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares during the period. AQR Capital Management LLC boosted its stake in Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after purchasing an additional 7,756 shares during the period. Empowered Funds LLC grew its holdings in Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after buying an additional 4,183 shares in the last quarter. First Trust Advisors LP grew its holdings in Astera Labs by 102.0% in the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after buying an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. increased its position in Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after buying an additional 1,977 shares during the period. 60.47% of the stock is owned by institutional investors.

Astera Labs Stock Down 0.4%

Astera Labs stock opened at $320.17 on Tuesday. The company has a market capitalization of $55.55 billion, a PE ratio of 158.50 and a beta of 3.84. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The firm’s fifty day moving average is $357.48 and its 200 day moving average is $241.79.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same period last year, the company posted $0.44 earnings per share. The business’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In related news, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. The trade was a 9.62% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of the company’s stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total value of $270,997.44. Following the transaction, the director directly owned 5,550 shares in the company, valued at $2,192,472. The trade was a 11.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 631,979 shares of company stock valued at $215,479,247. 10.40% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

ALAB has been the subject of a number of research reports. Bank of America lifted their target price on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Susquehanna boosted their target price on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a report on Friday, July 31st. TD Cowen cut their price target on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research report on Wednesday, August 5th. Finally, Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target for the company in a report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $333.00.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.